Labshake search
Citations for Tocris :
201 - 245 of 245 citations for Fatty acid binding protein FABP1 Human His since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2021Quote: ... B/D medium was supplemented during submerged culture with 1 nM EC23 (light-stable retinoic acid receptor agonist; Tocris, Abingdon, UK). After confluence was reached ...
-
bioRxiv - Neuroscience 2022Quote: ... containing 10 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 50 μM D,L-2-amino-5-phosphonovaleric acid (AP5) (both from Tocris, Bristol, UK) to block recurrent glutamatergic signaling.
-
bioRxiv - Neuroscience 2020Quote: ... to isolate inner retinal signaling (B-waves) and DL-2-Amino-4-phosphonobutyric acid (DL-AP4, 40µM, Tocris Bioscience, Bristol, U.K.) to isolate the photoreceptor component of the ERG signal (A-wave) ...
-
bioRxiv - Neuroscience 2023Quote: ... 5-(4-Bromophenyl)-3-(1,2-dihydro-6-methyl-2-oxo-4-phenyl-3-quinolinyl)-4,5-dihydro-γ-oxo-1H-pyrazole-1-butanoic acid (DQP 1105, 10 μM dissolved in DMSO; Tocris Bioscience), or 6-Cyano-7-nitroquinoxaline-2,3-dione disodium (CNQX ...
-
bioRxiv - Neuroscience 2023Quote: ... The following compounds were added to raCSF as indicated in the Results section: D-(-)-2-Amino-5-phosphonopentanoic acid (D-APV, 100 μM dissolved in H2O; Tocris Bioscience), (5S,10R)-(+)-5-Methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine maleate (MK-801 ...
-
bioRxiv - Neuroscience 2022Quote: ... was inserted into the guide cannula and a Hamilton Syringe was used to administrate 1 μL of 2 mM pyridoxalphosphate-6-azophenyl-2’,4’-disulfonic acid (PPADS, Tocris, 0625), 1.5 μg/μL S961 (Phoenix Pharmaceuticals ...
-
bioRxiv - Neuroscience 2023Quote: ... one day of medium d10 (Medium d3–9 with 200 µM ascorbic acid [Sigma-Aldrich, A4403], 125 µM db-cAMP [Tocris, 1141] ...
-
bioRxiv - Neuroscience 2023Quote: ... and 10 µM 6-imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid hydrobromide (SR95531;GABAA receptor antagonist; all from Tocris Bioscience).
-
bioRxiv - Cell Biology 2022Quote: ... The FFA2R antagonist CATPB ((S)-3-(2-(3-chlorophenyl)acetamido)-4-(4-(trifluoromethyl)-phenyl) butanoic acid) was from Tocris (Britsol, UK).
-
bioRxiv - Neuroscience 2023Quote: ... Mice were injected intraperitoneally (i.p.) with 5.0mg/kg synthetic kainic acid (KA) dissolved in 0.9% saline (#7065, Tocris Bioscience, Bristol, United Kingdom). At twenty-minute intervals ...
-
bioRxiv - Bioengineering 2023Quote: ... Rho-associated protein kinase (ROCK) (Y-27632, 25 µM, Tocris, UK), or phosphoinositide 3-kinase (PI3K ...
-
bioRxiv - Neuroscience 2021Quote: ... The bath solution usually contained 6,7-dinitroquinoxaline-2,3-dione (DNQX, 10 µM) and D- aminophosphonovaleric acid (D-APV, 50 µM) to block ionotropic glutamate receptors (Tocris, Abingdon, United Kingdom). Patch electrodes had resistances of 4-6 MΩ when filled with KMeSO4- or CMeSO4-based internal solution (same as used in vivo) ...
-
bioRxiv - Neuroscience 2020Quote: ... containing 10 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 50 μM D,L-2-amino-5-phosphonovaleric acid (AP5) to block glutamatergic signaling (both from Tocris, Bristol, UK). Experiments involving tetrodotoxin (TTX ...
-
bioRxiv - Neuroscience 2020Quote: ... 4-[(2S)-2-[(5-isoquinolinylsulfonyl)methylamino]-3-oxo-3-(4-phenyl-1-piperazinyl)propyl] phenyl isoquinolinesulfonic acid ester (KN-62; Tocris and HelloBio); D-AP5 (HelloBio) ...
-
bioRxiv - Neuroscience 2020Quote: ... co-applied with the competitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AMPA/kainate receptor antagonist CNQX (Tocris; 20 μM) (n=13) ...
-
bioRxiv - Neuroscience 2019Quote: ... (3S)-3-[[3-[[4-(Trifluoromethyl)benzoyl]amino]phenyl]methoxy]-L-aspartic acid (TFB-TBOA) was purchased from Tocris (Minneapolis, MN; Cat# 2532). All other chemicals were purchased from MilliporeSigma (Burlington ...
-
bioRxiv - Immunology 2020Quote: ... These cells were then directed to become proepicardial cells by the addition of retinoic acid and WNT CHIR 99021 followed by TGFβ inhibition (SB431542, Tocris Bioscience 1614). Finally ...
-
bioRxiv - Neuroscience 2023Quote: ... and cells were centrifuged at 200 rcf for 5 min and resuspended in N2B27 with the same supplements as on day 0 except for the removal of Y27632 and addition of all-trans retinoic acid (100 nM; Tocris, 0695/50) and SAG (500 nM ...
-
bioRxiv - Neuroscience 2020Quote: ... cells were resuspended in human embryonic stem cell (hESC) medium without bFGF2 supplemented with 1 µM dorsomorphin (Tocris), 3 µM CHIR99021 (Axon Medchem) ...
-
bioRxiv - Genomics 2019Quote: ... 20ng/ml human LIF (all from WT-MRC Cambridge Stem Cell Institute) and 2 μM Gö6983 (PKCi; Tocris) on Matrigel–coated plates (Corning) ...
-
bioRxiv - Cell Biology 2023Quote: ... 10 nM gastrin, 100 ng/ml recombinant human NRG1 (RD, 5898-NR) and 500 nM A83-01 (Tocris). Human mini-colons were maintained for 14 and 21 days ...
-
bioRxiv - Neuroscience 2020Quote: ... protein was first incubated with 300 μM Cyclothiazide (CTZ, Tocris, Cat# 0713) for at least 30 min on ice and then quickly mixed with 1 M L-glutamate stock solution to a final concentration of 100 mM prior to loading onto the grids ...
-
bioRxiv - Neuroscience 2021Quote: ... protein lysosomal degradation was inhibited with 100 μg/ml Leupeptin (Tocris, #1167) for 1h ...
-
bioRxiv - Neuroscience 2022Quote: ... protein was first incubated with 300 μM cyclothiazide (CTZ, Tocris, Cat# 0713) and 40 μM JNJ-059 for at least 30 min on ice and then quickly mixed with 1 M L-glutamate stock solution to a final concentration of 100 mM prior to loading onto the grids ...
-
bioRxiv - Developmental Biology 2022Quote: ... 10 μM Rho-associated protein kinase (ROCK) inhibitor Y-27632 (Tocris, 1254) was added to the culture medium for 24 hours.
-
bioRxiv - Neuroscience 2021Quote: ... and MNI-caged-L-glutamate ((S)-α-amino-2,3-dihydro-4-methoxy-7-nitro-δ-oxo-1H-indole-1-pentanoic acid) were purchased from Tocris (Bristol, UK). Rhod-2 tripotassium salt was purchased from AAT Bioquest (Sunnyvale ...
-
bioRxiv - Bioengineering 2023Quote: ... 10 nM gastrin, 50 ng/ml recombinant human EGF (R&D, 236-EG) and 500 nM A83-01 (Tocris). Organoids were passaged every 4 days by physical dissociation using fire-polished Pasteur pipettes.
-
bioRxiv - Bioengineering 2024Quote: ... supplemented with 50 ng/mL bone morphogenetic protein 4 (BMP4; Tocris; 314-BP) and 100 ng/mL activin A (Tocris ...
-
bioRxiv - Bioengineering 2024Quote: ... supplemented with 50 ng/mL bone morphogenetic protein 4 (BMP4; Tocris; 314-BP) and 100 ng/mL activin A (Tocris ...
-
bioRxiv - Neuroscience 2020Quote: ... The bath solution for recordings contained elevated concentrations of divalent cations [4 mM Ca2+ and 4 mM Mg2+] and NMDA receptor antagonist 3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) [5 mM] (Tocris biosciences, 126453-07-4). Slices were used 1.5–4.5 hours after preparation ...
-
bioRxiv - Neuroscience 2021Quote: ... A glass micropipette (tip diameter ∼ 30 µm) containing a 0.5M GABA solution (γ-aminobutyric acid; 0344, Tocris; dissolved in 0.9% w/v NaCl solution) was then advanced into the brain using a zero-drift micromanipulator under stereotaxic control ...
-
bioRxiv - Immunology 2019Quote: ... To test the effect of VIP on ILC3, cells were incubated with different concentrations of VIP (human, rat, mouse, rabbit, canine, porcine) from Tocris, Bay 55-9837 (Tocris) ...
-
bioRxiv - Cell Biology 2021Quote: Receptors were stimulated as follows: human Angiotensin 1 receptor (AT1R) with Angiotensin II (AngII; Tocris 4474-91-3, in measuring buffer), human β2 adrenergic receptor (β2ADR ...
-
bioRxiv - Genetics 2023Quote: ... When thawing KOLF2.1Js 10 µM Rho-associated protein kinase (ROCK) inhibitor (Y-27632) (Tocris, #1254) was added into the culture media overnight.
-
bioRxiv - Developmental Biology 2024Quote: ... The medium was supplemented with Rho-associated protein kinase (ROCK) inhibitor Y-27632(Tocris, 1254) at a final concentration of 10 µM for the first 24h after passaging ...
-
bioRxiv - Molecular Biology 2022Quote: ... and for degradation of tagged protein on treatment with dTAGV-1 (Tocris, #6914, reconstituted in DMSO). For all experiments involving dTAGV-1 treatment ...
-
bioRxiv - Cell Biology 2021Quote: H9 hESCs were treated with 10 µM Rho-associated protein kinase inhibitor (ROCKi, Tocris Bioscience #Y-27632) for 24 h before they were dissociated to single cells and pelleted ...
-
bioRxiv - Genetics 2021Quote: ... which were resuspended in mTeSR Plus media with 10 µM Rho-associated protein kinase inhibitor (ROCKi, Tocris Bioscience #Y-27632) for 24 h ...
-
bioRxiv - Immunology 2022Quote: ... SJL/J mice received a subcutaneous inguinal injection (100 μg/mouse) of the proteolipid protein (PLP) peptide (PLP139-151, Tocris) emulsified in complete Freund’s adjuvant (CFA ...
-
bioRxiv - Cancer Biology 2019Quote: ... Rho-associated protein kinases (ROCKs) were inhibited using Y-27632 dihydrochloride (Y27632, Selleckchem) and glycyl-H 1152 dihydrochloride (g-H-1152, Tocris); myosin light-chain kinase (MLCK ...
-
bioRxiv - Neuroscience 2022Quote: ... protein was incubated with 300 μM ZK200775 and 40 μM ligands (JNJ-61432059, MedChemExpress, Cat# HY-111751, JNJ- 55511118, Tocris, Cat#6278 ...
-
bioRxiv - Cell Biology 2022Quote: The mitogen-activated protein kinase kinase 1/2 (MEK1/2) inhibitor U0126 and the p38 MAPK inhibitor SB203580 were purchased from Tocris Bioscience (Bristol ...
-
bioRxiv - Cell Biology 2021Quote: COS-7 cells were transfected with plasmids for expression of KIF5C(1-560)-WT-Halo-Flag or KIF5C(1-560)-Δ6-Halo-Flag and the protein was fluorescently labelled by the inclusion of 50 nM JF552 Halo ligand (Tocris Bioscience) in the growth medium ...
-
bioRxiv - Bioengineering 2023Quote: ... Wnt signaling was inhibited (via the prevention of palmitylation of Wnt proteins by Porcn) from Days 12-19 using the small molecule Wnt-C59 (5 nM; Tocris 5148). After 35 days of differentiation ...
-
bioRxiv - Neuroscience 2021Quote: ... namely the mitogen activated protein kinase kinase (MAPKK) inhibitor U0126 (50 μM) and the CaM kinase II (CaMKII) inhibitor KN-62 (10 μM) (Tocris Bioscience, United Kingdom). The inhibitors were added to the cultures thirty minutes prior to DOI treatment ...